Search results
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 6 days ago“This approval is also the first time an mRNA vaccine has been approved for a disease other than Covid-19. With mRESVIA ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 hours ago...complaint, in September 2023, Gritstone entered into a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to run a 10,000 participant, randomized Phase 2b double-blinded study to compare the efficacy, safety, and immunogenicity of its COVID-19 vaccine candidate (a...
Moderna's RSV Vaccine Approved by FDA
Medscape· 6 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine& ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 6 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoThat way, you can have some time between shots before it’s time to get your fall flu shot and an...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 6 days agoThe RSV vaccine, known as mResvia, was approved to protect adults 60 years and older from lower...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 2 days agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 2 days agoThe Food and Drug Administration (FDA) today finally set a deadline to review the company's COVID-19 vaccine for full approval. Until ...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 4 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 2 days agoModerna has a couple of factors to back its strong run. Firstly, the U.S. FDA recently approved...
